A translational end-run for a rare, genetically enigmatic tumor

Cancer Biol Ther. 2009 Dec;8(24):2396-7. doi: 10.4161/cbt.8.24.10507. Epub 2009 Dec 3.
No abstract available

MeSH terms

  • Cell Line, Tumor
  • Chemistry, Pharmaceutical / methods
  • Drug Design
  • Enzyme Inhibitors / pharmacology
  • Gene Expression Regulation, Neoplastic*
  • Genetic Techniques
  • Humans
  • Medical Oncology / methods
  • Mutation
  • Neuroblastoma / drug therapy*
  • Neuroblastoma / genetics
  • Neuroblastoma / metabolism
  • RNA Interference
  • Signal Transduction

Substances

  • Enzyme Inhibitors